Sponsor:
St. Louis Children's Hospital
Code:
NCT02789969
Conditions
Pain
Nausea
Eligibility Criteria
Sex: All
Age: 3 - 10
Healthy Volunteers: Not accepted
Interventions
Hydromorphone
Fentanyl
Brief summary:
Conditions
Pain
Nausea
Study ID
NCT02789969
Start date
Apr, 2016
Status verified date
Jun, 2016
Completion date
Apr, 2017
Anticipated
Primary completion date
Mar, 2017
Anticipated
Eligibility Criteria
Sex: All
Age: 3 - 10
Healthy Volunteers: Not accepted
Enrollment
128 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Hydromorphone 15mcg/kg IV
experimental: Fentanyl 1.5 mcg/kg IV
Interventions
Hydromorphone
Fentanyl
Primary outcome measure
Central contacts
Locations
St. Louis Children's Hospital
Recruiting
St. Louis, Missouri, United States, 63110
Contacts
Sponsor
St. Louis Children's Hospital
Last update posted
Jun 3, 2016
Last verified
Jun, 2016
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by St. Louis Children's Hospital on 2016-06-03.